Actuate TherapeuticsACTU

13F holders, Q3 2025 (September 30)
43holders +5
7new positions
2sold out
$6.69avg. 13F price*

At the end of Q3 2025, 43 institutions reported holding Actuate Therapeutics Inc. (ACTU) in their 13F filings, up 5 from Q2 2025. 7 opened new positions and 2 sold out. The largest holders were BIOS Capital Management, LP ($67.2M), Voss Capital, LP ($6.0M) and Vanguard Group Inc. ($2.1M).

Company
Actuate Therapeutics Inc.
CUSIP
005083100
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q3 2024: 10Q3 2024Q4 2024: 19Q4 2024Q1 2025: 25Q1 2025Q2 2025: 38Q2 2025Q3 2025: 43Q3 2025Q4 2025: 45Q4 2025Q1 2026: 61Q1 2026Q2 2026: 62Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions7$46K
Exits2$100K

All 13F filers, Q2 2025 → Q3 2025: 910,738 shares bought and 101,757 shares sold, net +808,981 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 43 holders

BIOS Capital Management, LP 75.62% Add +0.8% 10,049,996 $67.2M
Voss Capital, LP 0.34% Add +213.2% 896,278 $6.0M
Vanguard Group Inc. 0.00% Add +19.5% 316,010 $2.1M
BlackRock, Inc. 0.00% Add +44.3% 282,074 $1.9M
Geode Capital Management, LLC 0.00% Add +23.2% 145,412 $973K
Northern Trust Corp. 0.00% Reduce -0.3% 85,454 $572K
State Street Corp. 0.00% Add +58.8% 49,895 $334K
Northwestern Mutual Wealth Management Co. 0.00% Add +4.2% 19,301 $129K
Gleason Group, Inc. 0.01% No change 19,028 $127K
Sfmg, LLC 0.01% Add +16.8% 17,000 $114K
LPL Financial LLC 0.00% Reduce -13.3% 16,215 $108K
Charles Schwab Investment Management Inc. 0.00% No change 14,765 $99K
Wells Fargo & Company 0.00% Add +5.8% 13,542 $91K
Royal Bank of Canada 0.00% Add +876.2% 12,954 $86K
Freestone Capital Holdings, LLC 0.00% No change 10,000 $67K
UBS Group AG 0.00% Add +280.4% 8,927 $60K
Barclays PLC 0.00% Reduce -76.3% 8,865 $59K
Rhumbline Advisers 0.00% Reduce -3.5% 8,768 $59K
Morgan Stanley 0.00% Reduce -1.5% 7,626 $51K
Northwestern University 0.08% Reduce -76.6% 6,488 $43K
Global Retirement Partners, LLC 0.00% No change 6,250 $42K
New York State Common Retirement Fund 0.00% Reduce -64.0% 6,200 $41K
Wealthspire Advisors, LLC 0.00% New 5,000 $33K
Bank of America Corp. 0.00% Reduce -68.1% 4,872 $33K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% Reduce -15.9% 2,683 $18K
JPMorgan Chase & Co. 0.00% Reduce -10.7% 2,484 $17K
Tower Research Capital LLC (TRC) 0.00% Add +12538.5% 1,643 $11K
BNP Paribas Financial Markets 0.00% Add +72.4% 1,560 $10K
Osaic Holdings, Inc. 0.00% No change 1,000 $8K
Deutsche Bank AG 0.00% Reduce -88.0% 1,258 $8K
Prosight Management, LP 0.00% New 885 $6K
Legal & General Group Plc 0.00% No change 708 $5K
Ameritas Investment Partners, Inc. 0.00% No change 601 $4K
FMR LLC 0.00% Add +84.2% 573 $4K
Russell Investments Group, Ltd. 0.00% New 487 $3K
PNC Financial Services Group, Inc. 0.00% New 384 $3K
California State Teachers Retirement System 0.00% Add +0.3% 368 $2K
Citigroup Inc. 0.00% Reduce -87.5% 260 $2K
Amalgamated Bank 0.00% No change 201 $1K
EverSource Wealth Advisors, LLC 0.00% New 70 $469
Arax Advisory Partners 0.00% New 60 $401
Sterling Capital Management LLC 0.00% Add +7.1% 15 $100
Cwm, LLC 0.00% New 51 $0

"% of holder's portfolio" is ACTU's weight in each manager's 13F, not the share of Actuate Therapeutics Inc. the manager owns.